USPTO serial 90843511
TRANSPLANT CONNECT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 16, 2022
- Examiner
- DAVIS, TRENTON MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TRANSPLANT CONNECT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark Andrew Goldstein
MARK ANDREW GOLDSTEIN SOCAL IP LAW GROUP LLP310 N WESTLAKE BLVD, STE 120WESTLAKE VILLAGE, CA 91362UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer application software for mobile phones and computing tablets, namely, software for entering, accessing, analyzing, sharing and communicating medical, clinical, financial, logistic and demographic information to facilitate human organ, eye and tissue donation, transplantation and research; Downloadable computer application software for mobile phones and computing tablets, namely, software for maintaining a database of medical, clinical, financial, demographic, operational and logistic information about human organ, eye and tissue donation, transplantation and research; Downloadable computer application software for mobile phones and computing tablets, namely, software for enabling communication and collaboration among persons involved in human organ, eye and tissue donation, transplant and research; Downloadable mobile applications for entering, accessing, analyzing, sharing and communicating medical, clinical, financial, logistic and demographic information to facilitate human organ, eye and tissue donation, transplantation and research; Downloadable mobile applications for maintaining a database of medical, clinical, financial, demographic, operational and logistic information about human organ, eye and tissue donation, transplantation and research; Downloadable mobile applications for enabling communication and collaboration among persons involved in human organ, eye and tissue donation, transplant and research; Downloadable software in the nature of a mobile application for entering, accessing, analyzing, sharing and communicating medical, clinical, financial, logistic and demographic information to facilitate human organ, eye and tissue donation, transplantation and research; Downloadable software in the nature of a mobile application for maintaining a database of medical, clinical, financial, demographic, operational and logistic information about human organ, eye and tissue donation, transplantation and research; Downloadable software in the nature of a mobile application for enabling communication and collaboration among persons involved in human organ, eye and tissue donation, transplant and research | ACTIVE | Jul 7, 2021 |
| 042 | Providing temporary use of a non-downloadable web application for entering, accessing, analyzing, sharing and communicating medical, clinical, financial, logistic and demographic information to facilitate human organ, eye and tissue donation, transplantation and research; Providing temporary use of a non-downloadable web application for maintaining a database of medical, clinical, financial, demographic, operational and logistic information about human organ, eye and tissue donation, transplantation and research; Providing temporary use of a non-downloadable web application for enabling communication and collaboration among persons involved in human organ, eye and tissue donation, transplant and research; Providing a website featuring non-downloadable software for entering, accessing, analyzing, sharing and communicating medical, clinical, financial, logistic and demographic information to facilitate human organ, eye and tissue donation, transplantation and research; Providing a website featuring non-downloadable software for maintaining a database of medical, clinical, financial, demographic, operational and logistic information about human organ, eye and tissue donation, transplantation and research; Providing a website featuring non-downloadable software for enabling communication and collaboration among persons involved in human organ, eye and tissue donation, transplant and research; Software as a service (SAAS) services featuring software for entering, accessing, analyzing, sharing and communicating medical, clinical, financial, logistic and demographic information to facilitate human organ, eye and tissue donation, transplantation and/or research; Software as a service (SAAS) services featuring software for maintaining a database of medical, clinical, financial, demographic, operational and logistic information about human organ, eye and tissue donation, transplantation and research; Software as a service (SAAS) services featuring software for enabling communication and collaboration among persons involved in human organ, eye and tissue donation, transplant and research; Software as a service (SAAS) services, namely, hosting software for use by others for use entering, accessing, analyzing, sharing and communicating medical, clinical, financial, logistic and demographic information to facilitate human organ, eye and tissue donation, transplantation and research; Software as a service (SAAS) services, namely, hosting software for use by others for use maintaining a database of medical, clinical, financial, demographic, operational and logistic information about human organ, eye and tissue donation, transplantation and research; Software as a service (SAAS) services, namely, hosting software for use by others for use enabling communication and collaboration among persons involved in human organ, eye and tissue donation, transplant and research | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Transplant Connect, Inc.
- Other trademarks owned by Transplant Connect, Inc.
- Other trademarks owned by Transplant Connect, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named TRANSPLANT CONNECT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 16, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 16, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 23, 2022 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| May 31, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 31, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 11, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 25, 2022 | ALIE | ASSIGNED TO LIE | — |
| Apr 22, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 21, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 21, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 21, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 21, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 15, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 4, 2022 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Sep 23, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 26, 2021 | NWAP | NEW APPLICATION ENTERED | — |